Department of Chemistry, University of California, Davis, One Shields Avenue, Davis, California 95616, USA.
J Org Chem. 2010 Aug 6;75(15):4891-8. doi: 10.1021/jo100366v.
Glycolipids containing alpha-linked galactosyl and glucosyl moieties have been shown to possess unique immunostimulatory activity creating a need for access to diverse and anomerically pure sources of these compounds for immunological studies. To meet this demand, glycosyl iodides were enlisted in the synthesis of these biologically relevant glycoconjugates. In the first-generation protocol, per-O-benzyl galactosyl iodide was efficiently coupled with activated sphingosine acceptors, but fully functionalized ceramides were found to be unreactive. To overcome this obstacle, per-O-trimethylsilyl glycosyl iodides were investigated and shown to undergo highly efficient coupling with ceramide and glycerol ester acceptors. Contrary to what has been observed with other donors, we detected little difference between the reactivity of glucosyl and galactosyl iodides. The trimethylsilyl protecting groups play a dual role in activating the donor toward nucleophilic attack while at the same time providing transient protection: the silyl groups are readily removed upon methanolysis. All reactions proceeded with complete acceptor regioselectivity, eliminating the need for additional protecting group manipulations, and the desired alpha-anomers were formed exclusively. This three-step, one-pot synthetic platform provides rapid access to an important class of immunostimulatory molecules including the first reported synthesis of the glucosyl analogue of the bacterial antigen BbGL-II.
含有α-连接的半乳糖基和葡萄糖基部分的糖脂已被证明具有独特的免疫刺激活性,这就需要获得多种和非对映纯的这些化合物来源,用于免疫学研究。为了满足这一需求,糖基碘化物被用于这些具有生物相关性的糖缀合物的合成中。在第一代方案中,全-O-苄基半乳糖基碘化物与活化的神经酰胺受体高效偶联,但全功能化的神经酰胺被发现没有反应性。为了克服这一障碍,研究了全-O-三甲基硅基糖基碘化物,并发现其与神经酰胺和甘油酯受体发生高度高效的偶联。与其他供体观察到的情况相反,我们发现葡萄糖基碘化物和半乳糖基碘化物的反应性几乎没有差异。三甲基硅基保护基在使供体朝向亲核进攻时起到双重作用,同时提供暂时的保护:在甲醇解时,硅烷基很容易被去除。所有反应都以完全的受体区域选择性进行,不需要额外的保护基操作,并且仅形成所需的α-异构体。这个三步一锅合成平台提供了快速获得一类重要的免疫刺激分子的途径,包括首次报道的细菌抗原 BbGL-II 的葡萄糖类似物的合成。